Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Artificial liver support in acute and acute-on-chronic liver failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Early haemorrhage control and management of trauma-induced coagulopathy: the importance of goal-directed therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Haemostatic resuscitation in trauma: the next generation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Stress ulcer prophylaxis in the intensive care unit

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hydroxyethyl starch for resuscitation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Acute liver failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Transcerebral exchange kinetics of large neutral amino acids during acute inspiratory hypoxia in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Lever- og galdevejssygdomme

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  3. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Reversal of Acute Liver Failure Due to Wilson Disease by a Regimen of High-Volume Plasma Exchange and Penicillamine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy-A Meta-Analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

PURPOSE OF REVIEW: Liver failure is a life-threatening condition, and an artificial liver is highly desirable to replace the failing liver-functions in the waiting time for liver regeneration to happen or until liver transplantation can be undertaken. This review focuses on the efficacy of using artificial extracorporeal liver support devices.

RECENT FINDINGS: Artificial liver support devices such as the molecular adsorbent recirculating system (MARS), fractionated plasma separation and adsorption, and therapeutic plasma exchange (TPE) are well tolerated. MARS and TPE improve systemic haemodynamics and the grade of hepatic encephalopathy. However, randomized, controlled trials of MARS and fractionated plasma separation and adsorption have failed to show improvement in survival in patients with acute liver failure (ALF) and patients with acute-on-chronic liver failure (ACLF). Only TPE improves survival in patients with ALF by ameliorate the release of ammonia, damage-associated molecular patterns and sB7 (CD80/86) from the necrotic liver. No randomized, controlled trials on survival in patients with ACLF using TPE have been done.

SUMMARY: Liver support systems such as MARS and TPE may temporarily improve systemic haemodynamics and the degree of encephalopathy. However, TPE is the only procedure that improves survival in patients with ALF. The role of TPE in ACLF remains unknown.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Critical Care
Vol/bind25
Udgave nummer2
Sider (fra-til)187-191
Antal sider5
ISSN1070-5295
DOI
StatusUdgivet - 2019

ID: 59435025